Phase III trial of gemcitabine plus docetaxel (GD) compared to capecitabine plus docetaxel (CD) with planned crossover to the alternate single agent in metastatic breast cancer (MBC) Meeting Abstract
| Authors: | Seidman, A. D.; Brufsky, A.; Ansari, R. H.; Rubinsak, J. R.; Stein, R. S.; Schwartzberg, L. S.; Stewart, J. F.; Zhao, L.; Gill, J.; Tai, D. |
| Abstract Title: | Phase III trial of gemcitabine plus docetaxel (GD) compared to capecitabine plus docetaxel (CD) with planned crossover to the alternate single agent in metastatic breast cancer (MBC) |
| Meeting Title: | 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 27 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2009 May 29-Jun 2 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2009-05-20 |
| Start Page: | 41s |
| Language: | English |
| ACCESSION: | WOS:000276606601479 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2009.27.15_suppl.1000 |
| Notes: | Meeting Abstract: 1000 -- Source: Wos |
